Evaluation of Pharmacokinetic/Pharmacodynamic Properties and Safety of Leucostim® Compared to Neupogen® in Healthy Adult Volunteers

Inclusion Criteria: * Age 19 - 45 years * BMI 18.5 - 25.0 kg/m2 * Value of ANC(absolute neutrophil count) had to be inside the normality range at the screening Exclusion Criteria: * Subjects with a history or presence of clinically relevant hypersensitivity reaction to investigational drugs (G-CSF) or their ingredients/additives * Subjects with a clinically relevant history of allergic reaction * Subjects with a history of acute infectious diseases within 2 weeks prior to administration of investigational products * At the investigator's discretion, subjects who is considered inappropriate to participate in the study due to any conditions including screening results